CAROLINE NEGRON: Open Payments
NPI 1487960340 · TORRANCE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,892 in 69 payments from 16 companies in 2025. Trend: 2023 $855 · 2024 $2,433 · 2025 $1,892
Food & beverage: $1,892
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $425 |
| Lilly USA, LLC | 10 | $384 |
| ABBVIE INC. | 8 | $181 |
| AstraZeneca Pharmaceuticals LP | 8 | $178 |
| GlaxoSmithKline, LLC. | 4 | $158 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $135 |
| Renalytix AI, Inc. | 4 | $96 |
| Amgen Inc. | 4 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| Exact Sciences Corporation | 3 | $54 |
Products named: JARDIANCE, Wegovy, Ozempic, ZEPBOUND, AREXVY, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT, UBRELVY, Kerendia.
Industry payments across CA — which companies pay providers there.
